Acceleration of α-synuclein aggregation by homologous peptides

被引:27
作者
Du, Hai-Ning
Li, Hong-Tao
Zhang, Feng
Lin, Xiao-Jing
Shi, Jia-Hao
Shi, Yan-Hong
Ji, Li-Na
Hu, Jun
Lin, Dong-Hai
Hu, Hong-Yu [1 ]
机构
[1] Chinese Acad Sci, Key Lab Prote, Inst Biochem & Cell Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China
[2] Shanghai Inst Appl Phys, Shanghai 201800, Peoples R China
[3] Shanghai Inst Biol Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China
基金
中国国家自然科学基金;
关键词
alpha-synuclein; GAV motif; aggregation; fibrillization; homologous peptide; Parkinson's disease;
D O I
10.1016/j.febslet.2006.05.050
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
alpha-Synuclein (alpha-Syn), amyloid beta-protein and prion protein are among the amyloidogenic proteins that are associated with the neurodegenerative diseases. These three proteins share a homologous region with a consensus sequence mainly consisting of glycine, alanine and valine residues (accordingly named as the GAV motif), which was proposed to be the critical core for the fibrillization and cytotoxicity. To understand the role of the GAV motif in protein amyloidogenesis, we studied the effects of the homologous peptides corresponding to the sequence of GAV motif region (residues 66-74) on alpha-Syn aggregation. The result shows that these peptides can promote fibrillization of wild-type a-Syn and induce that of the charge-incorporated mutants but not the GAV-deficient alpha-Syn mutant. The acceleration of a-Syn aggregation by the homologous peptides is under a sequence-specific manner. The interplay between the GAV peptide and the core regions in alpha-Syn may accelerate the aggregation process and stabilize the fibrils. This finding provides clues for developing peptide mimics that could promote transforming the toxic oligomers or protofibrils into the inert mature fibrils. (c) 2006 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:3657 / 3664
页数:8
相关论文
共 34 条
[1]   Amyloid fibril formation by Aβ16-22, a seven-residue fragment of the Alzheimer's β-amyloid peptide, and structural characterization by solid state NMR [J].
Balbach, JJ ;
Ishii, Y ;
Antzutkin, ON ;
Leapman, RD ;
Rizzo, NW ;
Dyda, F ;
Reed, J ;
Tycko, R .
BIOCHEMISTRY, 2000, 39 (45) :13748-13759
[2]   Identification of the region of non-Aβ component (NAC) of Alzheimer's disease amyloid responsible for its aggregation and toxicity [J].
Bodles, AM ;
Guthrie, DJS ;
Greer, B ;
Irvine, GB .
JOURNAL OF NEUROCHEMISTRY, 2001, 78 (02) :384-395
[3]   Fibrils formed in vitro from α-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid [J].
Conway, KA ;
Harper, JD ;
Lansbury, PT .
BIOCHEMISTRY, 2000, 39 (10) :2552-2563
[4]   Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease:: Implications for pathogenesis and therapy [J].
Conway, KA ;
Lee, SJ ;
Rochet, JC ;
Ding, TT ;
Williamson, RE ;
Lansbury, PT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (02) :571-576
[5]   From conversion to aggregation: Protofibril formation of the prion protein [J].
DeMarco, ML ;
Daggett, V .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (08) :2293-2298
[6]   α-Synuclein and the Lewy body disorders [J].
Dickson, DW .
CURRENT OPINION IN NEUROLOGY, 2001, 14 (04) :423-432
[7]   A peptide motif consisting of glycine, alanine, and valine is required for the fibrillization and cytotoxicity of human α-synuclein [J].
Du, HN ;
Tang, L ;
Luo, XY ;
Li, HT ;
Hu, J ;
Zhou, JW ;
Hu, HY .
BIOCHEMISTRY, 2003, 42 (29) :8870-8878
[8]   A strategy for designing inhibitors of α-synuclein aggregation and toxicity as a novel treatment for Parkinson's disease and related disorders [J].
El-Agnaf, OMA ;
Paleologou, KE ;
Greer, B ;
Abogrein, AM ;
King, JE ;
Salem, SA ;
Fullwood, NJ ;
Benson, FE ;
Hewitt, R ;
Ford, KJ ;
Martin, FL ;
Harriot, P ;
Cookson, MR ;
Allsop, D .
FASEB JOURNAL, 2004, 18 (09) :1315-+
[9]   The N-terminal region of non-Aβ component of Alzheimer's Disease amyloid is responsible for its tendency to assume β-sheet and aggregate to form fibrils [J].
El-Agnaf, OMA ;
Bodles, AM ;
Guthrie, DJS ;
Harriott, P ;
Irvine, GB .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1998, 258 (01) :157-163
[10]   Contribution of two conserved glycine residues to fibrillogenesis of the 106-126 prion protein fragment. Evidence that a soluble variant of the 106-126 peptide is neurotoxic [J].
Florio, T ;
Paludi, D ;
Villa, V ;
Principe, DR ;
Corsaro, A ;
Millo, E ;
Damonte, G ;
D'Arrigo, C ;
Russo, C ;
Schettini, G ;
Aceto, A .
JOURNAL OF NEUROCHEMISTRY, 2003, 85 (01) :62-72